Current Report Filing (8-k)
March 16 2022 - 04:37PM
Edgar (US Regulatory)
0001349706 false 0001349706 2022-03-16
2022-03-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
___________________________________________________________________
Date of Report (Date of earliest event
reported): March
16, 2022
IMPERALIS HOLDING CORP.
(Exact name of registrant as specified in its charter)
Nevada |
|
000-52140 |
|
20-5648820 |
(State or other jurisdiction of
incorporation or organization) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification
No.) |
11411 Southern Highlands Parkway,
Suite 240,
Las Vegas,
NV
89141
(Address of principal executive offices) (Zip Code)
(949)
444-5464
(Registrant's telephone number, including area code)
(Former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
None.
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If
an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
Item 5.02 Departure
of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
On
March 16, 2022, Henry Nisser resigned as the Chief Executive
Officer of Imperalis Holding Corp. (the “Company”) and as
the sole member of the Company’s Board of Directors (the
“Board”). Effective immediately upon Mr. Nisser’s
resignation, Darren Magot was appointed as the Company’s Chief
Executive Officer and sole member of the Board. Furthermore, of
even date herewith, the Board appointed Marcus Charuvastra to serve
as the Company’s President, effectively immediately.
Darren Magot has served as the Chief Executive officer and
sole member of the Board of Directors of AC Management, Inc., and
AMRE Management, Inc., since October 2020 and previously served as
the Chief Executive Officer and as a director of Ault Alliance,
Inc., from January 2019 to February 2022. Mr. Magot also currently
serves the Senior Vice President of BitNile, Inc., since his
appointment in February 2022, and as a member of the Board of
Directors of Ault & Company, Inc., since his appointment in
July 2018. Mr. Magot has over 30 years of experience in sales and
sales management, financial management, and business development
with companies in both the private and public sector. Expertise in
strategic planning, development, organizational change and
efficiency for disruptive and emerging technologies, M&A. A
proven leader in all functional areas of both private and public
organizations, with a track record in successful financial and
operational leadership, he holds a bachelor's degree in Finance
from California State University.
Marcus Charuvastra has served as the President of
TurnOnGreen, Inc., since January 2022 and previously served as its
Chief Revenue Officer since June 2021. Mr. Charuvastra is an
accomplished leader with 20 years of experience in strategic
planning, sales, services, marketing and business and
organizational development. Mr. Charuvastra spent nine years at
Targeted Medical Pharma, Inc. serving as Vice President of
Operations and as the Managing Director of this microcap biotech
start-up, from 2012 to May 2021. During his tenure, he was
instrumental in guiding Targeted Medical Pharma’s initial public
offering. Mr. Charuvastra was previously Director of Sales and
Marketing at Physician Therapeutics from 2009 to 2012 and was
responsible for building the sales and distribution network in the
United States and abroad. He is a graduate of UCLA.
Mr. Nisser’s resignation was not the result of a disagreement
between Mr. Nisser and the Company on any matter relating to the
Company’s operations, policies or practices.
There were no arrangements or understandings between the Company or
any other person and each of Messrs. Magot and Charuvastra pursuant
to his appointment.
There have been no transactions between each of Messrs. Magot and
Charuvastra and the Company other than those arising from his
employment agreement with the Company and no disclosure is required
under Item 404(a) of Regulation S-K.
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
IMPERALIS HOLDING CORP. |
|
|
|
|
Dated: March 16, 2022 |
/s/ Darren Magot |
|
|
Darren
Magot
Chief
Executive Officer
|
Imperalis (PK) (USOTC:IMHC)
Historical Stock Chart
From Dec 2022 to Jan 2023
Imperalis (PK) (USOTC:IMHC)
Historical Stock Chart
From Jan 2022 to Jan 2023